Dihydroergotamine Mesylate Injection Breastfeeding

Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Dihydroergotamine Mesylate Injection while breastfeeding. We will also discuss about common side effects and warnings associated with Dihydroergotamine Mesylate Injection.

What is Dihydroergotamine Mesylate Injection used for?


Dihydroergotamine Mesylate Injection is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Dihydroergotamine Mesylate Injection while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Dihydroergotamine Mesylate Injection high risk while breastfeeding
As Dihydroergotamine Mesylate Injection is made of only Dihydroergotamine mesylate, and Dihydroergotamine mesylate is unsafe to use in breastfeeding we can safely reach on conclusion that Dihydroergotamine Mesylate Injection is also unsafe to use while breastfeeding. Below is detailed analysis of Dihydroergotamine mesylate and Dihydroergotamine Mesylate Injection during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers Ergot drugs are known to inhibit prolactin. It is likely that dihydroergotamine mesylate is excreted in human milk, but there are no data on the concentration of dihydroergotamine in human milk. It is known that ergotamine is excreted in breast milk and may cause vomiting, diarrhea, weak pulse, and unstable blood pressure in nursing infants. Because of the potential for these serious adverse events in nursing infants exposed to dihydroergotamine mesylate, nursing should not be undertaken with the use of dihydroergotamine mesylate. (See CONTRAINDICATIONS .)

Dihydroergotamine Mesylate Injection Breastfeeding Analsys


Dihydroergotamine mesylate while Breastfeeding

Unsafe

CAS Number: 511-12-6

Ergot derivative alkaloid. It may inhibit prolactin secretion. It is used together with other substances (e.g. caffeine, which is a cause of anxiety). Multiple drug association is not recommended. On latest update relevant data on breastfeeding was not found. Sumatriptan which is a drug with well known low excretion into breast milk should be an alternative treatment for Migraine.


What should I do if already breastfed my kid after using Dihydroergotamine Mesylate Injection?

We have already established that Dihydroergotamine Mesylate Injection is unsafe in breastfeeding and breastfeeding while using Dihydroergotamine Mesylate Injection is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


I am nursing mother and my doctor has suggested me to use Dihydroergotamine Mesylate Injection, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Dihydroergotamine Mesylate Injection then there must be good reason for that as Dihydroergotamine Mesylate Injection is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Dihydroergotamine Mesylate Injection, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Dihydroergotamine Mesylate Injection and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Dihydroergotamine Mesylate Injection in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Migranal | Dihydroergotamine Mesylate Spray
Dihydroergotamine Mesylate Spray